10
WHAT, FOR YOU, IS THE SINGLE BIGGEST ISSUE OF IMPORTANCE IN RELATION TO THE REGULATORY FUNCTION RIGHT NOW, AND WHY?
Steve Gens (SG): It has to be improving global ways of working. Decreasing the time for market approvals has been the biggest area of focus and progress, not least having witnessed biopharma companies with COVID-19 products being able develop and gain regulatory approval in record time.
Login now to read the full article
Don’t have an account yet? Subscribe now, it’s free!
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt.
All pubblications
archive from 2022 to today
All articles
PDF Version
Receive our latest issue alerts
directly to your mailbox